Based on recent data, Larimar Therapeutics, Inc. (LRMR) shows an Average True Range (ATR) of 0.49 and an Enterprise Value of 390.95M. Its average trading volume over the past 3 months is 2.15M, indicating liquidity. These fundamental metrics provide insight into LRMR's underlying financial health and market activity.
| ATR | 0.49 |
| Enterprise Value | 390.95M |
| Avg Vol (3 Months) | 2.15M |
| Avg Vol (10 Days) | 2.36M |
Larimar Therapeutics, Inc. (LRMR) technical indicators as of July 10, 2026: the SMA 20 is 57.18%, SMA 50 at 55.73%, and SMA 200 at 56.96%. The RSI 14 value is 72.34, suggesting its current momentum. These technical analysis signals help assess LRMR's price trends and potential future movements.
| SMA 20 | 57.18% |
| SMA 50 | 55.73% |
| SMA 200 | 56.96% |
| RSI 14 | 72.34 |
Larimar Therapeutics, Inc. (LRMR) stock performance overview as of July 10, 2026: The 52-week high is $6.42 (currently -14.02% below), and the 52-week low is $2.72 (currently 242.86% above). Over the past year, LRMR's performance is -1.54%, compared to the S&P 500's 5.45% change.
| 52-Week High | 6.42 |
| 52-Week High Chg | -14.02% |
| 52-Week Low | 2.72 |
| 52-Week Low Chg | +242.86% |
| S&P 500 52-Week Chg | 5.45% |
According to market data, Larimar Therapeutics, Inc. (LRMR) stock's recent performance metrics show that over the last month, LRMR is -7.51%, with a Year-to-Date (YTD) performance of -16.01%. Over the past year, the stock has seen a -1.54% change. These figures summarize LRMR's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 4.28 | 4.28 | 5.35 | 6.42 | 6.42 | 6.42 |
| Low | 3.15 | 2.92 | 2.92 | 2.72 | 2.72 | 2.72 |
| Performance | -1.54% | -7.51% | -23.81% | -1.84% | -1.54% | -16.01% |
According to current financial data, LRMR stock's P/E (TTM) ratio is -1.99, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for LRMR, including P/S (N/A), P/B (2.26), and P/FCF (-2.73), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | LRMR | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -1.99 | -1.22 | -194.02 | 32.59 |
| P/S (TTM) | N/A | 3.68 | 466.98 | 5.98 |
| P/B (TTM) | 2.26 | 0.05 | 11.22 | 5.25 |
| P/FCF (TTM) | -2.73 | -9.47 | -613.7 | 29.69 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep